GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 36 filers reported holding GT BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,304 | -22.9% | 304,041 | -0.3% | 0.00% | – |
| Q2 2023 | $95,099 | -53.9% | 304,804 | -18.7% | 0.00% | – |
| Q1 2023 | $206,284 | -37.5% | 375,061 | +0.6% | 0.00% | – |
| Q4 2022 | $330,183 | -49.5% | 372,793 | +0.3% | 0.00% | – |
| Q3 2022 | $654,000 | -41.9% | 371,778 | -1.3% | 0.00% | – |
| Q2 2022 | $1,125,000 | -66.1% | 376,554 | -67.3% | 0.00% | – |
| Q1 2022 | $3,315,000 | -6.8% | 1,151,229 | -1.3% | 0.00% | – |
| Q4 2021 | $3,556,000 | -54.3% | 1,166,026 | +0.9% | 0.00% | – |
| Q3 2021 | $7,786,000 | -64.5% | 1,155,228 | -18.3% | 0.00% | -100.0% |
| Q2 2021 | $21,907,000 | – | 1,413,391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
| Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
| Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
| Welch Group, LLC | 10,000 | $29,000 | 0.00% |
| Renaissance Technologies | 186,300 | $537,000 | 0.00% |
| BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |